J. Coleman

发表

Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.

Han Liu, P. Russo, V. Reuter, 2013, European urology.

Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients

Donavan T. Cheng, Alexander V Penson, Benjamin E. Gross, 2017, Nature Medicine.

Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner.

C. N. Coleman, L. Whitcomb, G. Fichtinger, 2006, The Journal of urology.

Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.

Kenneth Offit, Barry S Taylor, Vignesh Ravichandran, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

Cyriac Kandoth, Mitchell C. Benson, Jonathan A. Coleman, 2018, Cell.

Preoperative predictive model of recovery of urinary continence after radical prostatectomy

P. Scardino, J. Eastham, O. Akin, 2015, BJU international.

Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

M. Zelefsky, J. Coleman, B. Carver, 2012, International journal of radiation oncology, biology, physics.

Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Ludmila V. Danilova, C. Sander, E. V. Van Allen, 2016, Genome Biology.

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Ludmila V. Danilova, C. Sander, E. V. Van Allen, 2016, Genome Biology.

Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes.

V. Laudone, J. Coleman, A. Vickers, 2018, European urology.

Cost comparison of open and robotic partial nephrectomy using a short postoperative pathway.

P. Russo, A. Hakimi, J. Coleman, 2015, Urology.

Comparison of gelatine matrix‐thrombin sealants used during laparoscopic partial nephrectomy

J. Coleman, Jordan M. Kurta, L. Nogueira, 2008, BJU international.

Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience.

David S. Yee, J. Coleman, M. Kaag, 2010, Urology.

Timing of blood transfusion and oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma

I. Ostrovnaya, J. Coleman, B. Bochner, 2018, World Journal of Urology.

Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development.

P. Choyke, W. Linehan, L. Schmidt, 2007, The Journal of urology.

A systematic review of outcomes after thermal and nonthermal partial prostate ablation

Antonio P. DeRosa, J. Coleman, B. Ehdaie, 2021, Prostate international.

Temporal changes in MRI appearance of the prostate after focal ablation

H. Hricak, O. Akin, J. Chaim, 2018, Abdominal Radiology.

The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma.

P. Russo, A. Hakimi, I. Ostrovnaya, 2019, Urologic oncology.

TOOKAD® soluble VTP: From local tumor ablation to systemic cancer control

A. Scherz, J. Coleman, Y. Salomon, 2017 .

Genomic Profile of Urothelial Carcinoma of the Upper Tract from Ureteroscopic Biopsy: Feasibility and Validation Using Matched Radical Nephroureterectomy Specimens.

J. Coleman, G. Iyer, H. Al-Ahmadie, 2018, European urology focus.

Reply from Authors re: R. Jeffrey Karnes. To What Extent Can We Predict Prostate Cancer Lymph Node Involvement ?

J. Coleman, G. Godoy, 2011 .

Reply from Authors re: R. Jeffrey Karnes. To What Extent Can We Predict Prostate Cancer Lymph Node Involvement? Eur Urol 2011;60:202–3

J. Coleman, G. Godoy, 2011 .

Bombesin Antagonist-Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy

A. Scherz, J. Coleman, W. Weber, 2017, Clinical Cancer Research.

Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer

A. Scherz, O. Cussenot, J. Wolchok, 2019, Oncoimmunology.

The landscape of T cell infiltration in human cancer and its association with antigen presenting gene expression

C. Sander, N. Weinhold, William Lee, 2015, bioRxiv.

The Prognostic Impact of a Positive Vascular Margin in pT3 Clear Cell Renal Cell Carcinomas

M. Bains, P. Russo, J. Wren, 2015 .

Erectile Function Recovery after Radical Prostatectomy in Men with High Risk Features.

V. Laudone, P. Scardino, J. Eastham, 2016, The Journal of urology.

Predictors of long-term renal function after kidney surgery for patients with preoperative chronic kidney disease.

P. Russo, J. Coleman, E. Reznik, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management.

P. Russo, V. Reuter, A. Hakimi, 2020, European urology.

PD10-05 OUTCOME OF GENETIC EVALUATION OF KIDNEY CANCER PATIENTS REFERRED FOR SUSPECTED HEREDITARY CANCER SYNDROMES

K. Offit, R. Klein, P. Russo, 2014 .

Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: a pilot study.

C. N. Coleman, N. Simone, C. Coleman, 2006, International journal of radiation oncology, biology, physics.

Radiofrequency ablation for tumor-related massive hematuria.

T. Fojo, J. Coleman, B. Wood, 2005, Journal of vascular and interventional radiology : JVIR.

Intraoperative mannitol use does not improve long-term renal function outcomes after minimally invasive partial nephrectomy.

P. Russo, J. Coleman, C. Savage, 2012, Urology.

The difficulty in selecting patients for cytoreductive nephrectomy: An evaluation of previously described predictive models.

P. Russo, A. Hakimi, J. Hsieh, 2017, Urologic oncology.

Special session on validating new procedures

Akshay K. Singh, L. Whitcomb, G. Fichtinger, 2013, International Journal of Computer Assisted Radiology and Surgery.

A case‐mix‐adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons

V. Laudone, P. Scardino, J. Eastham, 2013, BJU international.

Highlights from the Society of Urologic Oncology 4th annual meeting.

W. Linehan, J. Coleman, R. Grubb, 2005, The Journal of urology.

Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus.

A. Sidana, P. Choyke, S. Crouzet, 2020, European urology.

Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts

A. Scherz, J. Coleman, H. Lilja, 2018, Clinical Cancer Research.

Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer.

Timothy F. Donahue, J. Coleman, D. Danila, 2017, Urologic oncology.

Chromosomal and proteome analysis of a new T24‐based cell line model for aggressive bladder cancer

Antonia Vlahou, Jonathan Coleman, A. Vlahou, 2009, Proteomics.

Routine Postoperative Hemoglobin Assessment Poorly PredictsTransfusion Requirement among Patients Undergoing Minimally Invasive Radical Prostatectomy.

V. Laudone, P. Scardino, J. Eastham, 2020, Urology practice.

Contemporary Management of Hemorrhage After Minimally Invasive Radical Prostatectomy.

V. Laudone, J. Eastham, H. Vargas, 2019, Urology.

Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer.

J. Coleman, S. Solomon, J. Durack, 2016, The Journal of urology.

Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project

T. D. de Reijke, S. Crouzet, A. Villers, 2016, World Journal of Urology.

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.

A. Lenis, M. Ladanyi, K. Offit, 2021, European urology oncology.

The Efficacy of Multiparametric Magnetic Resonance Imaging and MRI-Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance

V. Laudone, J. Eastham, H. Vargas, 2017 .

Comparative Effectiveness of Targeted Prostate Biopsy Using MRI-US Fusion Software and Visual Targeting: a Prospective Study

P. Scardino, H. Vargas, J. Coleman, 2016 .

Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle‐invasive and non‐organ confined disease in patients with upper tract urothelial carcinoma

J. Coleman, B. Bochner, S. Shariat, 2012, BJU international.

The genetic basis of cancer of kidney cancer: implications for gene‐specific clinical management

W Marston Linehan, W. Linehan, M. Walther, 2005, BJU international.

Functional outcomes of partial prostate ablation and focal therapy: are we managing expectations of a bar set too high?

J. Coleman, 2015, Current opinion in urology.

Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.

Laura H. Tang, J. Coleman, H. Al-Ahmadie, 2008, Surgery.

COMPARATIVE GENOMIC PROFILING OF MATCHED PRIMARY AND METASTATIC TUMORS IN RENAL CELL CARCINOMA: MP39‐02

C. Bourque, N. Socci, R. Motzer, 2017, European urology focus.

Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary Tumors

A. Scherz, J. Coleman, Kwanghee Kim, 2017, Clinical Cancer Research.

A comparison of oncologic and functional outcomes in patients with pt3a renal cell carcinoma treated with partial and radical nephrectomy

P. Russo, J. Coleman, A. Tin, 2021, International braz j urol : official journal of the Brazilian Society of Urology.

Importance of long-term follow-up after endoscopic management for upper tract urothelial carcinoma and factors leading to surgical management

J. Coleman, S. Strope, A. Winer, 2020, International Urology and Nephrology.

Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage: A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative Morbidity.

P. Russo, J. Coleman, A. Vickers, 2020, European urology oncology.

Factors that affect proportional glomerular filtration rate after minimally invasive partial nephrectomy.

R. Ghavamian, A. Hakimi, J. Coleman, 2013, Journal of endourology.

Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell Carcinoma.

P. Russo, J. Coleman, A. Vickers, 2022, Clinical genitourinary cancer.

Focal therapy for primary and salvage prostate cancer treatment: a narrative review

J. Coleman, L. Nogueira, Katie S. Murray, 2021, Translational andrology and urology.

Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma

P. Russo, J. Coleman, E. Zabor, 2018, World Journal of Urology.

Targeted sequencing of upper tract urothelial carcinoma.

M. Berger, J. Coleman, G. Iyer, 2014 .

Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma

R. Motzer, P. Russo, A. Hakimi, 2021, Cancer.

Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Donavan T. Cheng, Alexander V Penson, Benjamin E. Gross, 2017, Nature Medicine.

High-resolution optoacoustic imaging of tissue responses to vascular-targeted therapies

A. Scherz, J. Coleman, V. Ntziachristos, 2020, Nature Biomedical Engineering.

TREATMENT EFFECTS OF WST11 VASCULAR TARGETED PHOTODYNAMIC THERAPY IN UROTHELIAL CELL CARCINOMA AND FEASIBILITY, SAFETY, AND LONG TERM OUTCOMES IN THE UPPER URINARY TRACT OF SWINE

A. Scherz, J. Coleman, H. Takaki, 2016 .

An Interventional MRI Technique for the Molecular Characterization of Heterogeneous Intra-Prostatic Dynamic Contrast Enhancement

C. N. Coleman, L. Whitcomb, L. Liotta, 2004 .

WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice

A. Scherz, J. Coleman, V. Ntziachristos, 2018, Theranostics.

Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series.

P. Russo, V. Reuter, A. Hakimi, 2019, Clinical genitourinary cancer.

Chromophobe renal cell carcinoma: results from a large single-institutional series

P. Russo, V. Reuter, I. Ostrovnaya, 2019 .

Adult Spermatic Cord Sarcomas: Management and Results

P. Russo, J. Coleman, M. Brennan, 2003, Annals of Surgical Oncology.

Importance of wide re‐resection in adult spermatic cord sarcomas: Report on oncologic outcomes at a single institution

P. Russo, J. Coleman, D. Sjoberg, 2018, Journal of surgical oncology.

Surgical Techniques in Urology xtended Pelvic Lymph Node Dissection n Robotic-assisted Radical Prostatectomy: urgical Technique and Initial Experience

J. Coleman, K. Chong, G. Godoy, 2022 .

A qualitative framework of non-selection factors for cytoreductive nephrectomy

P. Russo, R. Motzer, M. Voss, 2021, World Journal of Urology.

Have urinary function outcomes after radical prostatectomy improved over the past decade?

V. Laudone, P. Scardino, J. Eastham, 2021, Cancer.

Photoselective Vaporization of the Prostate in the Management of Lower Urinary Tract Symptoms in Prostate Cancer Patients on Active Surveillance.

J. Eastham, J. Coleman, D. Sjoberg, 2021, Urology.

Examining Mannitol Use in Kidney Cancer Surgery: A Cautionary Tale of Extrapolated Surgical Data.

J. Coleman, S. Nair, N. Power, 2019, European urology focus.

Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr Outcomes.

P. Russo, A. Hakimi, J. Coleman, 2019, European urology focus.

Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial.

P. Russo, J. Wren, J. Coleman, 2018, European urology.

Targeted Therapies in Advanced and Metastatic Urothelial Carcinoma

A. Lenis, J. Coleman, Kwanghee Kim, 2022, Cancers.

Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?

V. Laudone, P. Scardino, J. Eastham, 2018, Investigative and clinical urology.

Functional and oncological outcomes of renal surgery for hilar tumors: informing the decisions in risk-adapted management.

P. Russo, A. Hakimi, J. Coleman, 2021, Urology.

Lymph node dissection during robotic‐assisted laparoscopic prostatectomy: comparison of lymph node yield and clinical outcomes when including common iliac nodes with standard template dissection

David S. Yee, J. Coleman, K. Chong, 2010, BJU international.

Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures.

V. Laudone, P. Scardino, J. Eastham, 2012, Journal of endourology.

Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy

V. Laudone, J. Coleman, A. Vickers, 2022 .

Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.

J. Coleman, D. Sjoberg, G. Dalbagni, 2017, Urologic oncology.

Irreversible Electroporation for Prostate Cancer as Salvage Treatment Following Prior Radiation and Cryotherapy.

O. Akin, J. Coleman, Katie S. Murray, 2017, Reviews in urology.

Final Results of a Phase I/II Multicenter Trial of WST11 (TOOKAD ® Soluble) Vascular-Targeted Photodynamic Therapy (VTP) for Hemiablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Conducted in the United States

G. Andriole, J. Coleman, S. Taneja, 2017 .

Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape

P. Russo, V. Reuter, R. Motzer, 2022, Genome medicine.

T 2 and Dynamic Contrast Enhanced MR ( DCE-MRI ) Imaging of Prostate Cancer at 3 T

G. Metzger, C. Ménard, J. Coleman, 2005 .

Renal oncocytosis: management and clinical outcomes.

W. Lowrance, David S. Yee, P. Russo, 2011, The Journal of urology.

Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy

V. Laudone, P. Scardino, J. Eastham, 2012, Trials.

Dermatofibrosarcoma protuberans of the head and neck.

J. Coleman, J. Johnson, L. Barnes, 1984, Archives of otolaryngology.

Current and future imaging for urologic interventions

J. Coleman, S. Solomon, R. Nascimento, 2008, Current opinion in urology.

Macrophage-secreted TGF-β1 contributes to fibroblast activation and ureteral stricture after ablation injury.

J. Coleman, S. Solomon, J. Durack, 2019, American journal of physiology. Renal physiology.

The potential risk of tumor progression after use of dehydrated human amnion/chorion membrane allograft in a positive margin resection model

J. Coleman, Kwanghee Kim, S. Monette, 2019, Therapeutic advances in urology.

Ultrasonic tissue characterization of uveal melanoma and prediction of patient survival after enucleation and brachytherapy.

D J Coleman, R H Silverman, M J Rondeau, 1991, American journal of ophthalmology.

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

N. Schultz, R. Motzer, P. Russo, 2021, Clinical Cancer Research.

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy.

C. Leslie, P. Russo, V. Reuter, 2021, Cancer cell.

Ultrasound characterization of the infertile male testis with rf power spectrum analysis

Ronald H. Silverman, D. J. Coleman, Jonathan A. Coleman, 2002, SPIE Medical Imaging.

Genitourinary cancer predisposition syndromes.

J. Coleman, D. Gallagher, A. Feifer, 2010, Hematology/oncology clinics of North America.

Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Ludmila V. Danilova, C. Sander, E. V. Van Allen, 2017, Genome Biology.

Epidemiology of Renal Cell Carcinoma.

F. Bray, K. Bensalah, U. Capitanio, 2019, European urology.

Molecular classification and diagnostics of upper urinary tract urothelial carcinoma.

H. Aburatani, A. Lenis, H. Kume, 2021, Cancer cell.

Genomic Characterization of Upper Tract Urothelial Carcinoma.

N. Schultz, M. Berger, V. Reuter, 2015, European urology.

Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder

W. Linehan, J. Coleman, P. Pinto, 2014, Journal of Translational Medicine.

Evaluating localized prostate cancer and identifying candidates for focal therapy.

Mark A Rubin, Jonathan Coleman, Hedvig Hricak, 2008, Urology.

Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts

Jianjiong Gao, A. Hakimi, I. Ostrovnaya, 2020, Nature Communications.

B. Taylor, M. Berger, I. Ostrovnaya, 2018, Clinical Cancer Research.

Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch Syndrome

B. Taylor, J. Hopper, J. Coleman, 2018, JCO precision oncology.

Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer.

J. Eastham, M. Gleave, H. Beltran, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Genetic Signatures in Upper Tract Urothelial Carcinoma

J. Coleman, A. Bagrodia, E. Cha, 2016, Current Urology Reports.

Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma

Scott R. Kennedy, C. Sander, N. Schultz, 2019, eLife.

Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma

David S. Tourigny, P. Russo, J. Coleman, 2022, bioRxiv.

Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights.

W. Linehan, K. Offit, J. Brugarolas, 2019, European urology.

Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline.

J. Bishoff, S. Herrell, V. Reuter, 2013, The Journal of urology.

Identification of the Genes for Kidney Cancer: Opportunity for Disease-Specific Targeted Therapeutics

P. Choyke, W. Linehan, R. Srinivasan, 2007, Clinical Cancer Research.

Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.

P. Choyke, R. Grubb, W. Linehan, 2007, The Journal of urology.

Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma

K. Offit, P. Russo, J. Coleman, 2017, Cancer.

Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.

R. Motzer, P. Russo, I. Ostrovnaya, 2019, The Lancet. Oncology.

Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course.

R. Motzer, P. Russo, V. Reuter, 2019, European urology focus.

Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations.

R. Motzer, P. Russo, J. Hsieh, 2017, Urologic oncology.

Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.

R. Motzer, P. Russo, V. Reuter, 2017, European urology focus.

Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.

R. Motzer, P. Russo, A. Hakimi, 2017, Urologic oncology.

Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection

Chris Sander, Paul Russo, Yiyu Dong, 2017, Nature Communications.

Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples.

R. Motzer, P. Russo, A. Hakimi, 2016, European urology focus.

Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma.

H. Kume, Y. Homma, R. Motzer, 2016, European urology focus.

Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma

A. Jacobsen, K. Offit, R. Klein, 2016, Cancer.

Clinical utility of a custom next-generation sequencing panel in the diagnosis of needle biopsies from renal masses.

J. Coleman, S. Solomon, M. Janakiraman, 2016 .

TCEB1-mutated Renal Cell Carcinoma: A Distinct Genomic and Morphologic Subtype

C. Sander, H. Kume, Y. Homma, 2014, Modern Pathology.

The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling

R. Motzer, P. Russo, A. Hakimi, 2014, Cancer medicine.

Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a Cure.

R. Figlin, J. Brugarolas, T. Powles, 2020, Clinical genitourinary cancer.

Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression

R. Motzer, P. Russo, V. Reuter, 2020, Clinical Cancer Research.

Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma

M. Ladanyi, K. Offit, R. Motzer, 2018, JAMA oncology.

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

M. Berger, K. Offit, I. Ostrovnaya, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline.

Adam T Froemming, D. Margolis, P. Choyke, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma

J. Coleman, Kwanghee Kim, Katie S. Murray, 2020, Cancers.

Prognostic Value of TERT Alterations, Mutational and Copy Number Alterations Burden in Urothelial Carcinoma.

M. Berger, V. Reuter, I. Ostrovnaya, 2017, European urology focus.

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing

P. Kantoff, M. Ladanyi, M. Berger, 2017, JAMA.

Influence of hypoxia induced by minimally invasive prostatectomy on gene expression: implications for biomarker analysis.

J. Gillespie, M. Emmert-Buck, P. Albert, 2010, American journal of translational research.

c-Met Ectodomain Shedding Rate Correlates with Malignant Potential

C. Horak, J. Coleman, P. Steeg, 2006, Clinical Cancer Research.

An Arterial Based Complexity (ABC) Scoring System to Assess the Morbidity Profile of Partial Nephrectomy.

P. Russo, O. Akin, C. Karlo, 2016, European urology.

Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.

V. Laudone, J. Coleman, A. Vickers, 2015, European urology.

Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery.

Paul Russo, Jonathan Coleman, P. Russo, 2012, The Journal of urology.

Pirfenidone inhibits cryoablation induced local macrophage infiltration along with its associated TGFb1 expression and serum cytokine level in a mouse model.

J. Coleman, S. Solomon, J. Erinjeri, 2018, Cryobiology.

The association of renal cell carcinoma with gastrointestinal stromal tumors

P. Russo, A. Hakimi, J. Coleman, 2018, Journal of surgical oncology.

Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma

R. Motzer, P. Russo, A. Hakimi, 2021, Clinical Cancer Research.

Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer.

T. Choueiri, E. Plimack, J. Coleman, 2019, JAMA oncology.

Predicting length of stay after robotic partial nephrectomy

J. Coleman, D. Sjoberg, M. Bernstein, 2015, International Urology and Nephrology.

LBA-17 MULTICENTER PROSPECTIVE PHASE II CLINICAL TRIAL OF GEMCITABINE AND CISPLATIN AS NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA

J. Coleman, D. Sjoberg, G. Iyer, 2019, Journal of Urology.

Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction

V. Margulis, J. Coleman, S. Shariat, 2017, The Journal of urology.

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

E. V. Van Allen, N. Weinhold, William Lee, 2016, Genome Biology.

Robotic colectomy and repair of colovesical fistula due to diverticulitis ‐ a video vignette

J. Coleman, M. Weiser, J. Yuval, 2021, Colorectal Disease.

An evaluation of the role of tumor load in cytoreductive nephrectomy.

R. Motzer, P. Russo, O. Akin, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas

N. Schultz, P. Russo, V. Reuter, 2021, bioRxiv.

Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma

J. Coleman, B. Bochner, S. Shariat, 2013, BJU international.

MP39-09 GENOMIC CHARACTERIZATION OF AGGRESSIVE SPORADIC EPITHELIOID ANGIOMYOLIPOMA

P. Russo, R. Motzer, S. Tickoo, 2021 .

Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project

J. Coleman, H. Ahmed, L. Klotz, 2017, Prostate Cancer and Prostatic Diseases.

TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer

A. Scherz, J. Coleman, S. Taneja, 2015, World Journal of Urology.

Contemporary Role of Systematic Prostate Biopsies: Indications, Techniques, and Implications for Patient Care

Rodolfo Montironi, Osamu Ukimura, Mark Emberton, 2013 .

Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.

K. Offit, R. Klein, P. Russo, 2016, Urologic oncology.

Can kidney parenchyma metabolites serve as prognostic biomarkers for long-term kidney function after nephrectomy for renal cell carcinoma? A preliminary study

J. Coleman, R. Weiss, K. Suszták, 2020, Clinical kidney journal.

Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma.

M. Berger, V. Reuter, I. Ostrovnaya, 2016, The Journal of urology.

Comparison of open and minimally invasive partial nephrectomy for renal tumors 4-7 centimeters.

P. Russo, J. Coleman, G. Dalbagni, 2012, European urology.

Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia.

Joseph R. Scarpa, Joshua S. Mincer, P. Russo, 2020, British journal of anaesthesia.

Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma

V. Margulis, J. Coleman, M. Remzi, 2017, World Journal of Urology.

Survival Impact of Variant Histology Diagnosis in Upper Tract Urothelial Carcinoma

J. Coleman, H. Al-Ahmadie, D. Bajorin, 2022, The Journal of urology.

Feasibility of a Modified Biopsy Needle for Irreversible Electroporation Ablation and Periprocedural Tissue Sampling

J. Coleman, S. Solomon, M. Maybody, 2016, Technology in cancer research & treatment.

The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center.

J. Coleman, B. Bochner, S. Shariat, 2010, European urology.

Macrophage activity at the site of tumor ablation can promote murine urothelial cancer via transforming growth factor-β1

J. Coleman, H. Al-Ahmadie, H. Reis, 2023, Frontiers in Immunology.

Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model

A. Scherz, J. Coleman, Kwanghee Kim, 2021, Molecules.

Neoadjuvant vascular-targeted photodynamic therapy improves survival and reduces recurrence and progression in a mouse model of urothelial cancer

A. Scherz, J. Coleman, Kwanghee Kim, 2021, Scientific Reports.

Combined OX40 agonist and PD-1 inhibitor immunotherapy improves the efficacy of vascular targeted photodynamic therapy in a urothelial tumor model.

A. Scherz, J. Coleman, Kwanghee Kim, 2020 .

Effectiveness of the combination of vascular targeted photodynamic therapy and anti‐cytotoxic T‐lymphocyte‐associated antigen 4 in a preclinical mouse model of urothelial carcinoma

A. Scherz, J. Coleman, Kwanghee Kim, 2019, International journal of urology : official journal of the Japanese Urological Association.

Normal Porcine Ureter Retains Lumen Wall Integrity but Not Patency Following Catheter-Directed Irreversible Electroporation: Imaging and Histologic Assessment over 28 Days.

J. Coleman, S. Solomon, J. Durack, 2017, Journal of vascular and interventional radiology : JVIR.

Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in Swine.

A. Scherz, J. Coleman, H. Takaki, 2016, The Journal of urology.

Feasibility of catheter-directed intraluminal irreversible electroporation of porcine ureter and acute outcomes in response to increasing energy delivery.

J. Coleman, S. Solomon, J. Durack, 2015, Journal of vascular and interventional radiology : JVIR.

Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.

J. Coleman, S. Matin, P. Spiess, 2015, The Journal of urology.

The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.

V. Laudone, J. Eastham, H. Vargas, 2016, The Journal of urology.

Recovery of renal function after open and laparoscopic partial nephrectomy.

Paul Russo, Jonathan Coleman, B. Guillonneau, 2010, European urology.

Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study.

Jonathan Coleman, Hebert Alberto Vargas, P. Scardino, 2016, The Journal of urology.

Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer

John Kurhanewicz, Oguz Akin, Mark Emberton, 2012, BJU international.

Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States.

Leonard Marks, Mark Emberton, Jonathan Coleman, 2016, The Journal of urology.

Transperineal Mapping Biopsy of the Prostate for Assessment of the Minimal Risk Patient

J. Coleman, 2013 .

Low yield of surveillance imaging after surgery for T1 kidney cancer

P. Russo, H. Vargas, J. Coleman, 2016, World Journal of Urology.

Advances in imaging for urologic procedures

J. Coleman, S. Solomon, R. Nascimento, 2007, Nature Clinical Practice Urology.

Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.

P. Scardino, J. Eastham, M. Zelefsky, 2021, Urologic oncology.

Reply from Authors re: Amnon Zisman. Laparoscopic Nephroureterectomy: Is It Always as Good as Open Nephroureterectomy? Eur Urol 2010;58:652–3

J. Coleman, G. Dalbagni, R. Favaretto, 2010 .

Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?

J. Coleman, B. Bochner, S. Shariat, 2010, European urology.

Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract

J. Coleman, A. Winer, P. Zaręba, 2017, Cancer.

Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma

A. Hakimi, H. Vargas, J. Coleman, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MP77-14 CAN PRE-OPERATIVE CT IDENTIFY POSITIVE LYMPH NODES IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA?

J. Coleman, P. Kim, J. Sfakianos, 2014 .

Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness

P. Scardino, A. Scherz, J. Coleman, 2018, The Journal of urology.

Accuracy analysis in MRI-guided robotic prostate biopsy

Andras Lasso, Gabor Fichtinger, Peter A. Pinto, 2013, International Journal of Computer Assisted Radiology and Surgery.

Focal Therapy: Current Status and Future Directions

P. Scardino, J. Coleman, B. Ehdaie, 2015 .

Patient selection determines the prostate cancer yield of dynamic contrast‐enhanced magnetic resonance imaging‐guided transrectal biopsies in a closed 3‐Tesla scanner

Gabor Fichtinger, Axel Krieger, Ashutosh Kumar Singh, 2007, BJU international.

Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.

A. Vlahou, J. Coleman, G. Panayotou, 2010, Journal of proteome research.

Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution

P. Russo, J. Coleman, E. Zabor, 2016, World Journal of Urology.

The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-year Institutional Experience.

P. Russo, A. Hakimi, S. Tickoo, 2019, Urology.

Narrow Band Imaging in the Evaluation of Upper Tract Urothelial Cancer

J. Coleman, H. Herr, B. Rosenzweig, 2018 .

Comparison of perioperative outcomes of retroperitoneal and transperitoneal minimally invasive partial nephrectomy after adjusting for tumor complexity.

J. Coleman, E. Vertosick, M. Bernstein, 2014, Urology.

The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.

R. Motzer, P. Russo, T. Choueiri, 2019, European urology oncology.

Clinical Outcomes in Patients with Panurothelial Carcinoma Treated with Radical Nephroureterectomy Following Cystectomy for Metachronous Recurrence

J. Coleman, G. Dalbagni, E. Pietzak, 2017, The Journal of urology.

Perforation of the peptic ulceration in the elderly.

J. Coleman, M. Denham, 1980, Age and ageing.

Metastatic renal cell carcinoma risk according to tumor size.

P. Russo, R. Thompson, J. Coleman, 2009, The Journal of urology.

Assessing renal function after partial nephrectomy using renal nuclear scintigraphy and estimated glomerular filtration rate.

J. Coleman, D. Sjoberg, J. Sfakianos, 2012, Urology.

Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model.

Majid Maybody, J. Coleman, S. Solomon, 2011, Urology.

Planning Irreversible Electroporation in the Porcine Kidney: Are Numerical Simulations Reliable for Predicting Empiric Ablation Outcomes?

Thomas Wimmer, Stephen B. Solomon, Jeremy C. Durack, 2015, CardioVascular and Interventional Radiology.

High-resolution optoacoustic imaging of tissue responses to vascular-targeted therapies

A. Scherz, J. Coleman, V. Ntziachristos, 2020, Nature Biomedical Engineering.

Inguinal hernia of the distal ureter causing hydronephrosis: A rare case

J. Coleman, Matthew T. Smith, N. Wong, 2020, Urology Case Reports.

Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.

Guilherme Godoy, V. Laudone, B. Guillonneau, 2011, European urology.

MRI‐safe robot for targeted transrectal prostate biopsy: animal experiments

Dan Stoianovici, Doru Petrisor, Chunwoo Kim, 2014, BJU international.

Hereditary and familial kidney cancer.

P. Russo, J. Coleman, 2009, Current opinion in urology.

Familial and hereditary renal cancer syndromes.

J. Coleman, 2008, The Urologic clinics of North America.

The association between modifiable perioperative parameters and renal function after nephrectomy

Joshua S. Mincer, P. Russo, A. Hakimi, 2021, BJU international.

Magnetic resonance imaging‐directed transrectal ultrasonography‐guided biopsies in patients at risk of prostate cancer

Ashutosh Kumar Singh, Peter Choyke, Iclal Ocak, 2007, BJU international.

Developments in Vascular-Targeted Photodynamic Therapy for Urologic Malignancies

A. Scherz, J. Coleman, Kwanghee Kim, 2020, Molecules.

Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design.

M. Gross, D. D. de Bruin, A. Villers, 2015, Urologic oncology.

Targeted prostate cancer ablation: energy options

P. Scardino, J. Coleman, 2013, Current opinion in urology.

Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma

A. Scherz, J. Coleman, D. Sjoberg, 2023, The Journal of urology.

Four-year Follow-up of a Phase-3 Prospective Randomized Trial of Partial Gland Ablation with Vascular- Targeted Phototherapy versus Active Surveillance for Low-risk Prostate Cancer

P. Scardino, A. Scherz, J. Coleman, 2018 .

Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.

D. Lifshitz, J. Gore, P. Pierorazio, 2020, The Lancet. Oncology.

Surgical Approaches to Treatment of Renal Cell Carcinoma 49

P. Russo, J. Coleman, 2013 .

Comparison of ablation defect on MR imaging with computer simulation estimated treatment zone following irreversible electroporation of patient prostate

Stephen B. Solomon, Jeremy C. Durack, Jonathan A. Coleman, 2016, SpringerPlus.

Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model.

A. Scherz, J. Coleman, J. Grimm, 2019, European urology focus.

Nonthermal Ablation by Using Intravascular Oxygen Radical Generation with WST11: Dynamic Tissue Effects and Implications for Focal Therapy.

P. Scardino, A. Scherz, J. Coleman, 2016, Radiology.

Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysis.

M. Kattan, P. Russo, O. Akin, 2021, Urologic oncology.

Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort.

M. Kattan, P. Russo, O. Akin, 2020, Urologic oncology.

Postoperative nomogram for disease recurrence and cancer-specific death for upper tract urothelial carcinoma: comparison to American Joint Committee on Cancer staging classification.

J. Coleman, S. Shariat, G. Dalbagni, 2014, Urology journal.

LBA-16 NEPHRON-SPARING MANAGEMENT OF LOW GRADE (LG) UTUC WITH UGN-101 (MITOMYCIN GEL) FOR INSTILLATION: THE OLYMPUS TRIAL EXPERIENCE

D. Lifshitz, J. Gore, J. Coleman, 2019, Journal of Urology.

Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report

D. Lifshitz, J. Gore, P. Pierorazio, 2021, The Journal of urology.

Impact of Ureteroscopy Before Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes.

J. Coleman, D. Sjoberg, A. Tin, 2016, Urology.

Endoscopic spray cryotherapy for genitourinary malignancies: safety and efficacy in a porcine model

V. Rusch, J. Coleman, Y. Fong, 2013, Therapeutic advances in urology.

Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline

R. Chou, S. Psutka, Sam S. Chang, 2023, The Journal of urology.

Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscleinvasive and non-organ confined disease in patients with upper tract urothelial carcinoma

J. Coleman, B. Bochner, S. Shariat, 2011 .

Validation of 3D volumetric-based renal function prediction calculator for nephron sparing surgery

H. Vargas, J. Coleman, S. Nougaret, 2017, International Urology and Nephrology.

Radio frequency ablation of small renal tumors:: intermediate results.

W. Linehan, M. Walther, James Peterson, 2004, The Journal of urology.

Cancer predisposing germline mutations in patients (pts) with urothelial cancer (UC) of the renal pelvis (R-P), ureter (U) and bladder (B).

K. Offit, A. Hakimi, J. Coleman, 2017 .

Radiofrequency-assisted laparoscopic partial nephrectomy: clinical and histologic results.

J. Coleman, B. Wood, W. Pritchard, 2007, Journal of endourology.

MP59-02 IMPACT OF URETEROSCOPY PRIOR TO NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA ON ONCOLOGIC OUTCOMES

J. Coleman, D. Sjoberg, A. Tin, 2015 .

Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy

W. Lowrance, E. Elkin, L. Jacks, 2011, Cancer.

New treatments for localized prostate cancer.

Hedvig Hricak, P. Carroll, H. Hricak, 2008, Urology.

Platinum Priority – Review – Kidney Cancer

F. Bray, K. Bensalah, U. Capitanio, 2018 .

Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy.

P. Russo, O. Akin, R. Motzer, 2022, European Urology.

An intravenous fluorophore for enhanced intraoperative nerve visualization

Jonathan A. Coleman, Vincent P. Laudone, Peter T. Scardino, 2021, BiOS.

The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm.

P. Russo, A. Hakimi, J. Coleman, 2016, Urologic oncology.

The natural history of large renal masses followed on observation.

P. Russo, A. Hakimi, J. Coleman, 2018, Urologic oncology.

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear Cell Renal Cell Carcinoma.

S. Lowe, R. Motzer, P. Russo, 2022, Cancer discovery.

Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI.

H. Hricak, P. Scardino, O. Akin, 2010, Urology.

Design of a novel MRI compatible manipulator for image guided prostate interventions

Gabor Fichtinger, Axel Krieger, Louis L. Whitcomb, 2005, IEEE Transactions on Biomedical Engineering.

LBA-12 CALGB 90203 (ALLIANCE): RADICAL PROSTATECTOMY WITH OR WITHOUT NEOADJUVANT CHEMOHORMONAL THERAPY IN MEN WITH CLINICALLY LOCALIZED, HIGH RISK PROSTATE CANCER

J. Eastham, M. Gleave, H. Beltran, 2019, Journal of Urology.

Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinoma.

R. Motzer, P. Russo, I. Ostrovnaya, 2019, Urologic oncology.

Visualization, Planning, and Monitoring Software for MRI-Guided Prostate Intervention Robot

Gabor Fichtinger, Emese Balogh, Axel Krieger, 2004, MICCAI.

The Effect of Patient and Surgical Characteristics on Renal Function After Partial Nephrectomy

P. Russo, J. Coleman, E. Zabor, 2017, Clinical genitourinary cancer.

MRI-Safe Robot for Endorectal Prostate Biopsy

Stephen B. Solomon, Doru Petrisor, Chunwoo Kim, 2014, IEEE/ASME Transactions on Mechatronics.

A Comparative Study of Ablation Boundary Sharpness After Percutaneous Radiofrequency, Cryo-, Microwave, and Irreversible Electroporation Ablation in Normal Swine Liver and Kidneys

J. Coleman, S. Solomon, J. Durack, 2017, CardioVascular and Interventional Radiology.

CALGB 90203 (Alliance): Radical prostatectomy (RP) with or without neoadjuvant chemohormonal therapy (CHT) in men with clinically localized, high-risk prostate cancer (CLHRPC).

J. Eastham, M. Gleave, H. Beltran, 2019, Journal of Clinical Oncology.

RISK OF METASTATIC RENAL CELL CARCINOMA ACCORDING TO TUMOR SIZE

P. Russo, R. Thompson, J. Coleman, 2009 .

Highlights from the Society of Urologic Oncology, 5th Annual Meeting, December 3-4, 2004, Bethesda, Maryland, United States of America.

W. Linehan, J. Coleman, R. Grubb, 2005, The Journal of urology.

Phase 2b trial results of padeliporfin (WST11 or Tookad) vascular-targeted photodynamic therapy for partial gland ablation in men with intermediate-risk prostate cancer.

V. Laudone, P. Scardino, J. Eastham, 2021 .

Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems

Oguz Akin, Omer Aras, Jonathan A. Coleman, 2015, World Journal of Urology.

Focal Treatment of Prostate Cancer with Vascular-Targeted Photodynamic Therapy

Jonathan A. Coleman, J. Coleman, S. Eggener, 2008, TheScientificWorldJournal.

Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging

P. Russo, O. Akin, S. Tickoo, 2018, The Journal of urology.

Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive Nephrectomy

P. Russo, M. Voss, J. Coleman, 2023, The Journal of urology.

Nephrometry scores and perioperative outcomes following robotic partial nephrectomy

P. Russo, J. Coleman, D. Sjoberg, 2017, International braz j urol : official journal of the Brazilian Society of Urology.

Contrast enhanced ultrasound imaging can predict vascular-targeted photodynamic therapy induced tumor necrosis in small animals.

A. Scherz, J. Coleman, J. Durack, 2017, Photodiagnosis and photodynamic therapy.

Vascular-Targeted Photodynamic Therapy for Prostate Cancer

A. Scherz, J. Coleman, Katie S. Murray, 2021, Interventional Urology.

An Interventional Magnetic Resonance Imaging Technique for the Molecular Characterization of Intraprostatic Dynamic Contrast Enhancement

Axel Krieger, Peter Guion, Ergin Atalar, 2005, Molecular imaging.

V. Laudone, J. Coleman, A. Vickers, 2023, The Journal of urology.

Critical evaluation of perioperative complications in laparoscopic partial nephrectomy.

B. Guillonneau, J. Coleman, C. Savage, 2010, Urology.

Immunometabolic coevolution defines unique microenvironmental niches in ccRCC.

N. Schultz, Wesley Tansey, R. Motzer, 2023, Cell metabolism.

Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy.

P. Russo, I. Ostrovnaya, S. Tickoo, 2023, Urologic oncology.

Resource-efficient pooled sequencing expands translational impact in solid tumors

M. Berger, Nicole Rusk, P. Russo, 2021, bioRxiv.

RENAL MASS AND LOCALIZED RENAL CANCER: EVALUATION, MANAGEMENT, AND FOLLOW-UP: AUA GUIDELINE

Karam, Peter Clark, J. Cadeddu, 2021 .

Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Donavan T. Cheng, Benjamin E. Gross, Michael H. Eubank, 2017, Nature Network Boston.

Biopsy of Small Renal Masses Should be Routinely Performed before Deciding Treatment: Con.

J. Coleman, 2017, The Journal of urology.

Cold intravascular organ perfusion for renal hypothermia during laparoscopic partial nephrectomy.

J. Coleman, Jordan M. Kurta, T. Siegrist, 2011, The Journal of urology.

Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patients

Nimrod D. Rubinstein, P. Russo, O. Akin, 2017, PloS one.

Functional outcomes of partial prostate ablation and focal therapy: are we managing expectations of a bar set too high?

J. Coleman, 2015, Current opinion in urology.

Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods-what's around the corner?

J. Coleman, K. Thomas, E. Tham, 2023, World journal of urology.

Endoscopic spray cryotherapy for genitourinary malignancies: safety and efficacy in a porcine model

V. Rusch, J. Coleman, Y. Fong, 2013, Therapeutic advances in urology.

MP21-04 NEUTROPHIL-TO-LYMPHOCYTE RATIO IN UNCLASSIFIED RENAL CELL CARCINOMA IS ASSOCIATED WITH PROGNOSIS AND VARIES BETWEEN MOLECULAR SUBGROUPS

R. Motzer, P. Russo, J. Coleman, 2019, Journal of Urology.

Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma.

C. Bourque, N. Socci, R. Motzer, 2017, European urology focus.

Hereditary and familial kidney cancer.

P. Russo, J. Coleman, 2009, Current opinion in urology.

The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.

M. Bains, P. Russo, J. Wren, 2016, The Journal of urology.

Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.

V. Laudone, B. Guillonneau, P. Scardino, 2011, European urology.

Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.

R. Motzer, P. Russo, A. Hakimi, 2017, Urologic oncology.

Mismatch repair deficiency and microsatellite instability-high in urothelial carcinoma: A systematic review and meta-analysis.

J. Coleman, M. Teo, A. Apolo, 2023, Journal of Clinical Oncology.

Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive Nephrectomy

P. Russo, M. Voss, J. Coleman, 2023, The Journal of urology.